PT606452E - Vacinas de vector de virus de herpes felino recombinante - Google Patents

Vacinas de vector de virus de herpes felino recombinante

Info

Publication number
PT606452E
PT606452E PT93917639T PT93917639T PT606452E PT 606452 E PT606452 E PT 606452E PT 93917639 T PT93917639 T PT 93917639T PT 93917639 T PT93917639 T PT 93917639T PT 606452 E PT606452 E PT 606452E
Authority
PT
Portugal
Prior art keywords
fhv
recombinant feline
vector vectors
feline herpes
mutant
Prior art date
Application number
PT93917639T
Other languages
English (en)
Inventor
Paulus Jacobus An Sondermeijer
Martha Jacoba Willemse
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8210815&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT606452(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of PT606452E publication Critical patent/PT606452E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16711Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compression Or Coding Systems Of Tv Signals (AREA)
  • Peptides Or Proteins (AREA)
PT93917639T 1992-07-30 1993-07-23 Vacinas de vector de virus de herpes felino recombinante PT606452E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92202365 1992-07-30

Publications (1)

Publication Number Publication Date
PT606452E true PT606452E (pt) 2003-03-31

Family

ID=8210815

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93917639T PT606452E (pt) 1992-07-30 1993-07-23 Vacinas de vector de virus de herpes felino recombinante

Country Status (10)

Country Link
US (1) US6521236B1 (pt)
EP (1) EP0606452B1 (pt)
JP (1) JP3529134B2 (pt)
AT (1) ATE227775T1 (pt)
AU (1) AU4702293A (pt)
DE (1) DE69332480T2 (pt)
DK (1) DK0606452T3 (pt)
ES (1) ES2187508T3 (pt)
PT (1) PT606452E (pt)
WO (1) WO1994003621A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995000172A1 (en) * 1993-06-24 1995-01-05 Michigan State University Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof
ES2267101T3 (es) * 1994-04-29 2007-03-01 PHARMACIA & UPJOHN COMPANY LLC Vacuna contra virus de inmunodeficiencia felina.
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
US7279168B2 (en) 1998-05-01 2007-10-09 Texas A & M University System Recombinant virus expressing foreign DNA encoding feline CD86 and uses thereof
CZ20003934A3 (cs) * 1998-05-01 2001-09-12 Schering-Plough Ltd. Rekombinantní virus exprimující cizí DNA kódující kočičí CD80, kočičí CTLA-4 nebo kočičí CD-86 a jeho použití
JP2002112770A (ja) 2000-10-05 2002-04-16 Kyoritsu Seiyaku Kk 新規組換えネコヘルペスウイルス1型およびこれを用いた多価ワクチン
WO2009051823A2 (en) * 2007-10-18 2009-04-23 Michigan State University Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950000887B1 (ko) * 1985-07-29 1995-02-03 디 엎죤 캄파니 프로제니터 비루스 왁찐 조성물, 이의 제조방법, 및 이를 사용하여 비루스에 감염된 동물과 왁찐 주사를 맞은 동물을 구별하기 위한 방법
US5223424A (en) * 1985-09-06 1993-06-29 Prutech Research And Development Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
EP0256092B1 (en) * 1986-01-27 1998-04-08 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
US5324664A (en) * 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
EP0431668B1 (en) * 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
WO1995000172A1 (en) 1993-06-24 1995-01-05 Michigan State University Recombinant deletion feline herpesvirus vaccine and method for the preparation thereof

Also Published As

Publication number Publication date
DK0606452T3 (da) 2003-03-17
WO1994003621A1 (en) 1994-02-17
EP0606452B1 (en) 2002-11-13
DE69332480T2 (de) 2003-07-17
EP0606452A1 (en) 1994-07-20
ES2187508T3 (es) 2003-06-16
US6521236B1 (en) 2003-02-18
JP3529134B2 (ja) 2004-05-24
JPH06511392A (ja) 1994-12-22
ATE227775T1 (de) 2002-11-15
AU4702293A (en) 1994-03-03
DE69332480D1 (de) 2002-12-19

Similar Documents

Publication Publication Date Title
CA2031164A1 (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
OA09777A (en) "Viral defective vaccine produced by transcomplementing cell line"
CA2161962A1 (en) Adenovirus vectors for gene therapy
MX9700833A (es) Virus de herpes recombinante de pavo y usos del mismo.
AU6861487A (en) Recombinant herpes simplex viruses, vaccines and methods
EP0596979A4 (en) Recombinant plant viral nucleic acids.
EP0677114A4 (en) RECOMBINED PIGROCK VIRUS.
PT576092E (pt) Vacina de virus de herpes felino recombinante
PT606452E (pt) Vacinas de vector de virus de herpes felino recombinante
NO922728L (no) Vaksine mot coccidiose
NZ508892A (en) Nucleic acid encoding a vaccine-induced mutant major surface antigen of a hepatitis B viral strain
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
HUT69793A (en) Recombinant adenovirus vaccines
HU9201590D0 (en) Recombinant vaccine against marek's illness
CA2196416A1 (en) Recombinant herpes virus with gb gene promoter
CY2540B1 (en) Vaccine against mumps containing a jeryl-lynn virus strain
Willemse et al. Recombinant feline herpesvirus vaccine
MY118955A (en) Mutant human hepatitis b viral strain and uses thereof.
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
Keil Vector vaccines of bovine herpesvirus I
MX9709514A (es) Viruses de fowlpox recombinantes y usos de los mismos.